Cargando…
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
Autores principales: | Blackburn, C., Gigstad, K. M., Hales, P., Garcia, K., Jones, M., Bruzzese, F. J., Barrett, C., Liu, J. X., Soucy, T. A., Sappal, D. S., Bump, N., Olhava, E. J., Fleming, P., Dick, L. R., Tsu, C., Sintchak, M. D., Blank, J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871146/ |
Ejemplares similares
-
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
por: Blackburn, Christopher, et al.
Publicado: (2010) -
Identification
of Potent and Selective Non-covalent
Inhibitors of the Plasmodium falciparum Proteasome
por: Li, Hao, et al.
Publicado: (2014) -
A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency
por: Stern, Daniel, et al.
Publicado: (2018) -
Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi
por: Csizmadia, Vilmos, et al.
Publicado: (2016) -
Prednisolone exerts exquisite inhibitory properties on platelet functions
por: Liverani, Elisabetta, et al.
Publicado: (2012)